Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Kidney Follow-up for AKI Survivors in Care Transitions (The ACT Study): Impact on Patient Reported Outcomes

NCT04505891 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04505891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions (The ACT Study): Impact on Patient Reported Outcomes
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2020
Completion date
December 21, 2021
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury